FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: A systematic review and meta-analysis

Yu Yu Lu, Jin Hua Chen, Wan Yu Lin, Ji An Liang, Hsin Yi Wang, Shih Chuan Tsai, Chia Hung Kao

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Aim: The purpose of the current study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT for intramedullary and extramedullary lesions in multiple myeloma. Methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of intramedullary and extramedullary lesions in multiple myeloma. Results: Fourteen studies with a total of 395 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FDG PET or PET/CT for the detection of extramedullary lesions in multiple myeloma were 96.0% [95% confidence interval (CI), 79.6%-99.9%], 77.8% (95% CI, 40.0%-97.2%), 3.28 (95% CI, 1.29-8.32), and 0.12 (95% CI, 0.03-0.42), respectively. The pooled estimates of sensitivity, specificity, LR+, and LR-of FDG PET or PET/CT for the detection of intramedullary lesions in multiple myeloma were 61.1% (95% CI, 43.5%-76.9%), 94.1% (95% CI, 71.3%-99.9%), 5.73 (95% CI, 1.53-21.40), and 0.43 (95% CI, 0.28-0.65), respectively. Conclusions: Whole-body FDG PET or PET/CT is a valuable imaging tool for the assessment of patients with multiple myeloma, especially for the appraisal of extramedullary involvement.

Original languageEnglish
Pages (from-to)833-837
Number of pages5
JournalClinical Nuclear Medicine
Volume37
Issue number9
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Fingerprint

Multiple Myeloma
Meta-Analysis
Confidence Intervals
Sensitivity and Specificity
MEDLINE
ROC Curve

Keywords

  • FDG PET
  • meta-analysis
  • multiple myeloma
  • PET/CT
  • systematic review

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma : A systematic review and meta-analysis. / Lu, Yu Yu; Chen, Jin Hua; Lin, Wan Yu; Liang, Ji An; Wang, Hsin Yi; Tsai, Shih Chuan; Kao, Chia Hung.

In: Clinical Nuclear Medicine, Vol. 37, No. 9, 09.2012, p. 833-837.

Research output: Contribution to journalArticle

Lu, Yu Yu ; Chen, Jin Hua ; Lin, Wan Yu ; Liang, Ji An ; Wang, Hsin Yi ; Tsai, Shih Chuan ; Kao, Chia Hung. / FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma : A systematic review and meta-analysis. In: Clinical Nuclear Medicine. 2012 ; Vol. 37, No. 9. pp. 833-837.
@article{e0ba952f6db34ce5ba9414d1cdf0883a,
title = "FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: A systematic review and meta-analysis",
abstract = "Aim: The purpose of the current study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT for intramedullary and extramedullary lesions in multiple myeloma. Methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of intramedullary and extramedullary lesions in multiple myeloma. Results: Fourteen studies with a total of 395 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FDG PET or PET/CT for the detection of extramedullary lesions in multiple myeloma were 96.0{\%} [95{\%} confidence interval (CI), 79.6{\%}-99.9{\%}], 77.8{\%} (95{\%} CI, 40.0{\%}-97.2{\%}), 3.28 (95{\%} CI, 1.29-8.32), and 0.12 (95{\%} CI, 0.03-0.42), respectively. The pooled estimates of sensitivity, specificity, LR+, and LR-of FDG PET or PET/CT for the detection of intramedullary lesions in multiple myeloma were 61.1{\%} (95{\%} CI, 43.5{\%}-76.9{\%}), 94.1{\%} (95{\%} CI, 71.3{\%}-99.9{\%}), 5.73 (95{\%} CI, 1.53-21.40), and 0.43 (95{\%} CI, 0.28-0.65), respectively. Conclusions: Whole-body FDG PET or PET/CT is a valuable imaging tool for the assessment of patients with multiple myeloma, especially for the appraisal of extramedullary involvement.",
keywords = "FDG PET, meta-analysis, multiple myeloma, PET/CT, systematic review",
author = "Lu, {Yu Yu} and Chen, {Jin Hua} and Lin, {Wan Yu} and Liang, {Ji An} and Wang, {Hsin Yi} and Tsai, {Shih Chuan} and Kao, {Chia Hung}",
year = "2012",
month = "9",
doi = "10.1097/RLU.0b013e31825b2071",
language = "English",
volume = "37",
pages = "833--837",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - FDG PET or PET/CT for detecting intramedullary and extramedullary lesions in multiple myeloma

T2 - A systematic review and meta-analysis

AU - Lu, Yu Yu

AU - Chen, Jin Hua

AU - Lin, Wan Yu

AU - Liang, Ji An

AU - Wang, Hsin Yi

AU - Tsai, Shih Chuan

AU - Kao, Chia Hung

PY - 2012/9

Y1 - 2012/9

N2 - Aim: The purpose of the current study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT for intramedullary and extramedullary lesions in multiple myeloma. Methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of intramedullary and extramedullary lesions in multiple myeloma. Results: Fourteen studies with a total of 395 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FDG PET or PET/CT for the detection of extramedullary lesions in multiple myeloma were 96.0% [95% confidence interval (CI), 79.6%-99.9%], 77.8% (95% CI, 40.0%-97.2%), 3.28 (95% CI, 1.29-8.32), and 0.12 (95% CI, 0.03-0.42), respectively. The pooled estimates of sensitivity, specificity, LR+, and LR-of FDG PET or PET/CT for the detection of intramedullary lesions in multiple myeloma were 61.1% (95% CI, 43.5%-76.9%), 94.1% (95% CI, 71.3%-99.9%), 5.73 (95% CI, 1.53-21.40), and 0.43 (95% CI, 0.28-0.65), respectively. Conclusions: Whole-body FDG PET or PET/CT is a valuable imaging tool for the assessment of patients with multiple myeloma, especially for the appraisal of extramedullary involvement.

AB - Aim: The purpose of the current study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of FDG PET or PET/CT for intramedullary and extramedullary lesions in multiple myeloma. Methods: The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of intramedullary and extramedullary lesions in multiple myeloma. Results: Fourteen studies with a total of 395 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FDG PET or PET/CT for the detection of extramedullary lesions in multiple myeloma were 96.0% [95% confidence interval (CI), 79.6%-99.9%], 77.8% (95% CI, 40.0%-97.2%), 3.28 (95% CI, 1.29-8.32), and 0.12 (95% CI, 0.03-0.42), respectively. The pooled estimates of sensitivity, specificity, LR+, and LR-of FDG PET or PET/CT for the detection of intramedullary lesions in multiple myeloma were 61.1% (95% CI, 43.5%-76.9%), 94.1% (95% CI, 71.3%-99.9%), 5.73 (95% CI, 1.53-21.40), and 0.43 (95% CI, 0.28-0.65), respectively. Conclusions: Whole-body FDG PET or PET/CT is a valuable imaging tool for the assessment of patients with multiple myeloma, especially for the appraisal of extramedullary involvement.

KW - FDG PET

KW - meta-analysis

KW - multiple myeloma

KW - PET/CT

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=84865583663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865583663&partnerID=8YFLogxK

U2 - 10.1097/RLU.0b013e31825b2071

DO - 10.1097/RLU.0b013e31825b2071

M3 - Article

C2 - 22889770

AN - SCOPUS:84865583663

VL - 37

SP - 833

EP - 837

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -